Meta Biomed Statistics

Total Valuation

Meta Biomed has a market cap or net worth of KRW 89.54 billion. The enterprise value is 103.81 billion.

Market Cap	89.54B
Enterprise Value	103.81B

Important Dates

The next estimated earnings date is Thursday, November 14, 2024.

Earnings Date	Nov 14, 2024
Ex-Dividend Date	n/a

Share Statistics

Meta Biomed has 22.87 million shares outstanding. The number of shares has increased by 6.71% in one year.

Shares Outstanding	22.87M
Shares Change (YoY)	+6.71%
Shares Change (QoQ)	+16.02%
Owned by Insiders (%)	25.32%
Owned by Institutions (%)	7.09%
Float	17.08M

Valuation Ratios

The trailing PE ratio is 7.13.

PE Ratio	7.13
Forward PE	n/a
PS Ratio	0.99
PB Ratio	1.12
P/FCF Ratio	14.99
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.13, with an EV/FCF ratio of 17.37.

EV / Earnings	7.01
EV / Sales	1.15
EV / EBITDA	6.13
EV / EBIT	8.41
EV / FCF	17.37

Financial Position

The company has a current ratio of 1.13, with a Debt / Equity ratio of 0.69.

Current Ratio	1.13
Quick Ratio	0.85
Debt / Equity	0.69
Debt / EBITDA	3.36
Debt / FCF	9.53
Interest Coverage	4.26

Financial Efficiency

Return on equity (ROE) is 19.34% and return on invested capital (ROIC) is 6.05%.

Return on Equity (ROE)	19.34%
Return on Assets (ROA)	5.23%
Return on Capital (ROIC)	6.05%
Revenue Per Employee	324.07M
Profits Per Employee	53.24M
Employee Count	278
Asset Turnover	0.61
Inventory Turnover	3.25

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.44% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+1.44%
50-Day Moving Average	4,111.80
200-Day Moving Average	4,411.70
Relative Strength Index (RSI)	46.55
Average Volume (20 Days)	104,015

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Meta Biomed had revenue of KRW 90.09 billion and earned 14.80 billion in profits. Earnings per share was 551.65.

Revenue	90.09B
Gross Profit	41.67B
Operating Income	12.35B
Pretax Income	12.68B
Net Income	14.80B
EBITDA	16.94B
EBIT	12.35B
Earnings Per Share (EPS)	551.65

Full Income Statement

Balance Sheet

The company has 45.35 billion in cash and 56.95 billion in debt, giving a net cash position of -11.61 billion or -507.54 per share.

Cash & Cash Equivalents	45.35B
Total Debt	56.95B
Net Cash	-11.61B
Net Cash Per Share	-507.54
Equity (Book Value)	82.57B
Book Value Per Share	3,494.19
Working Capital	9.27B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 18.95 billion and capital expenditures -12.98 billion, giving a free cash flow of 5.98 billion.

Operating Cash Flow	18.95B
Capital Expenditures	-12.98B
Free Cash Flow	5.98B
FCF Per Share	261.25

Full Cash Flow Statement

Margins

Gross margin is 46.25%, with operating and profit margins of 13.71% and 16.43%.

Gross Margin	46.25%
Operating Margin	13.71%
Pretax Margin	14.08%
Profit Margin	16.43%
EBITDA Margin	18.80%
EBIT Margin	13.71%
FCF Margin	6.63%

Dividends & Yields

This stock pays an annual dividend of 20.00, which amounts to a dividend yield of 0.51%.

Dividend Per Share	20.00
Dividend Yield	0.51%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	3.09%
Buyback Yield	-6.71%
Shareholder Yield	-6.20%
Earnings Yield	14.09%
FCF Yield	6.67%

Dividend Details

Stock Splits

The last stock split was on April 23, 2010. It was a forward split with a ratio of 2.

Last Split Date	Apr 23, 2010
Split Type	Forward
Split Ratio	2

Scores

Meta Biomed has an Altman Z-Score of 1.83. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.83
Piotroski F-Score	n/a